Tokyo Tape
Sign in
← Mochida Pharmaceutical

Annual report

4534.TEDINET S100YI28
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥117.0bn2025-04-01 → 2026-03-31Cons.Net sales
Revenue¥105.2bn2024-04-01 → 2025-03-31Cons.Net sales
Revenue¥102.9bn2023-04-01 → 2024-03-31vCons.Net sales (5-year summary)
Revenue¥103.3bn2022-04-01 → 2023-03-31vCons.Net sales (5-year summary)
Revenue¥110.2bn2021-04-01 → 2022-03-31vCons.Net sales (5-year summary)
Operating income¥10.1bn2025-04-01 → 2026-03-31Cons.Operating income
Operating income¥8.1bn2024-04-01 → 2025-03-31Cons.Operating income
Ordinary income¥11.2bn2025-04-01 → 2026-03-31Cons.Ordinary income
Ordinary income¥8.1bn2024-04-01 → 2025-03-31Cons.Ordinary income
Ordinary income¥6.0bn2023-04-01 → 2024-03-31vCons.Ordinary income loss (5-year summary)
Ordinary income¥9.1bn2022-04-01 → 2023-03-31vCons.Ordinary income loss (5-year summary)
Ordinary income¥14.8bn2021-04-01 → 2022-03-31vCons.Ordinary income loss (5-year summary)
Profit before tax¥11.2bn2025-04-01 → 2026-03-31Cons.Income before income taxes
Profit before tax¥8.1bn2024-04-01 → 2025-03-31Cons.Income before income taxes
Net income (owners)¥7.9bn2025-04-01 → 2026-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.7bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.5bn2023-04-01 → 2024-03-31vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.6bn2022-04-01 → 2023-03-31vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥10.6bn2021-04-01 → 2022-03-31vCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥7.9bn2025-04-01 → 2026-03-31Cons.Profit loss
Net income¥5.7bn2024-04-01 → 2025-03-31Cons.Profit loss
Total assets¥182.7bnat 2026-03-31Cons.Assets
Total assets¥160.1bnat 2025-03-31Cons.Assets
Total assets¥158.8bnat 2024-03-31vCons.Total assets (5-year summary)
Total assets¥158.8bnat 2023-03-31vCons.Total assets (5-year summary)
Total assets¥163.1bnat 2022-03-31vCons.Total assets (5-year summary)
Total liabilities¥42.4bnat 2026-03-31Cons.Liabilities
Total liabilities¥29.4bnat 2025-03-31Cons.Liabilities
Net assets / equity¥140.3bnat 2026-03-31Cons.Net assets
Net assets / equity¥130.7bnat 2025-03-31Cons.Net assets
Net assets / equity¥128.0bnat 2024-03-31vCons.Net assets
Net assets / equity¥126.8bnat 2023-03-31vCons.Net assets (5-year summary)
Net assets / equity¥128.6bnat 2022-03-31vCons.Net assets (5-year summary)
Cash and deposits¥28.1bnat 2026-03-31Cons.Cash and deposits
Cash and deposits¥45.2bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥31.1bnat 2026-03-31Cons.Cash and cash equivalents
Cash & equivalents¥48.2bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥24.3bnat 2024-03-31vCons.Cash and cash equivalents
Cash & equivalents¥38.0bnat 2023-03-31vCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥40.5bnat 2022-03-31vCons.Cash and cash equivalents (5-year summary)
Operating cash flow−¥7.3bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥9.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥7.5bn2023-04-01 → 2024-03-31vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥7.3bn2022-04-01 → 2023-03-31vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥7.5bn2021-04-01 → 2022-03-31vCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥16.8bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in investment activities
Investing cash flow¥17.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investment activities
Investing cash flow¥74m2023-04-01 → 2024-03-31vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.9bn2022-04-01 → 2023-03-31vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.0bn2021-04-01 → 2022-03-31vCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥7.0bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥6.4bn2023-04-01 → 2024-03-31vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥6.9bn2022-04-01 → 2023-03-31vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥6.0bn2021-04-01 → 2022-03-31vCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥222.962025-04-01 → 2026-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥160.362024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥126.82023-04-01 → 2024-03-31vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥178.932022-04-01 → 2023-03-31vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥277.392021-04-01 → 2022-03-31vCons.Basic earnings loss per share (5-year summary)
Net assets per share¥3,958.46at 2026-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥3,686.69at 2025-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥3,609.64at 2024-03-31vCons.Net assets per share (5-year summary)
Net assets per share¥3,470.18at 2023-03-31vCons.Net assets per share (5-year summary)
Net assets per share¥3,424.21at 2022-03-31vCons.Net assets per share (5-year summary)
Equity ratio76.8%at 2026-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.6%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio80.6%at 2024-03-31vCons.Equity to asset ratio (5-year summary)
Equity ratio79.8%at 2023-03-31vCons.Equity to asset ratio (5-year summary)
Equity ratio78.9%at 2022-03-31vCons.Equity to asset ratio (5-year summary)
ROE5.8%2025-04-01 → 2026-03-31Cons.Rate of return on equity (5-year summary)
ROE4.4%2024-04-01 → 2025-03-31Cons.Rate of return on equity (5-year summary)
ROE3.6%2023-04-01 → 2024-03-31vCons.Rate of return on equity (5-year summary)
ROE5.2%2022-04-01 → 2023-03-31vCons.Rate of return on equity (5-year summary)
ROE8.3%2021-04-01 → 2022-03-31vCons.Rate of return on equity (5-year summary)
Employees1,479at 2026-03-31Cons.Number of employees
Employees1,508at 2025-03-31Cons.Number of employees
Employees1,522at 2024-03-31vCons.Number of employees
Employees1,529at 2023-03-31vCons.Number of employees
Employees1,544at 2022-03-31vCons.Number of employees
Revenue¥106.1bn2025-04-01 → 2026-03-31StandaloneNet sales
Revenue¥95.4bn2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥94.2bn2023-04-01 → 2024-03-31vStandaloneNet sales (5-year summary)
Revenue¥95.5bn2022-04-01 → 2023-03-31vStandaloneNet sales (5-year summary)
Revenue¥102.4bn2021-04-01 → 2022-03-31vStandaloneNet sales (5-year summary)
Operating income¥6.4bn2025-04-01 → 2026-03-31StandaloneOperating income
Operating income¥5.5bn2024-04-01 → 2025-03-31StandaloneOperating income
Ordinary income¥8.7bn2025-04-01 → 2026-03-31StandaloneOrdinary income
Ordinary income¥7.6bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income¥5.4bn2023-04-01 → 2024-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥9.0bn2022-04-01 → 2023-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥13.5bn2021-04-01 → 2022-03-31vStandaloneOrdinary income loss (5-year summary)
Profit before tax¥8.6bn2025-04-01 → 2026-03-31StandaloneIncome before income taxes
Profit before tax¥6.9bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Net income¥6.6bn2025-04-01 → 2026-03-31StandaloneProfit loss
Net income¥5.4bn2024-04-01 → 2025-03-31StandaloneProfit loss
Net income¥4.7bn2023-04-01 → 2024-03-31vStandaloneNet income loss (5-year summary)
Net income¥7.3bn2022-04-01 → 2023-03-31vStandaloneNet income loss (5-year summary)
Net income¥10.4bn2021-04-01 → 2022-03-31vStandaloneNet income loss (5-year summary)
Total assets¥172.3bnat 2026-03-31StandaloneAssets
Total assets¥153.1bnat 2025-03-31StandaloneAssets
Total assets¥152.2bnat 2024-03-31vStandaloneTotal assets (5-year summary)
Total assets¥152.4bnat 2023-03-31vStandaloneTotal assets (5-year summary)
Total assets¥156.8bnat 2022-03-31vStandaloneTotal assets (5-year summary)
Total liabilities¥35.9bnat 2026-03-31StandaloneLiabilities
Total liabilities¥24.7bnat 2025-03-31StandaloneLiabilities
Net assets / equity¥136.4bnat 2026-03-31StandaloneNet assets
Net assets / equity¥128.5bnat 2025-03-31StandaloneNet assets
Net assets / equity¥126.3bnat 2024-03-31vStandaloneNet assets
Net assets / equity¥125.1bnat 2023-03-31vStandaloneNet assets (5-year summary)
Net assets / equity¥126.4bnat 2022-03-31vStandaloneNet assets (5-year summary)
Cash and deposits¥20.9bnat 2026-03-31StandaloneCash and deposits
Cash and deposits¥40.5bnat 2025-03-31StandaloneCash and deposits
EPS (basic)¥184.942025-04-01 → 2026-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥151.872024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥130.272023-04-01 → 2024-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥195.12022-04-01 → 2023-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥274.032021-04-01 → 2022-03-31vStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥802025-04-01 → 2026-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥802024-04-01 → 2025-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥802023-04-01 → 2024-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥802022-04-01 → 2023-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥902021-04-01 → 2022-03-31vStandaloneDividend paid per share (5-year summary)
Net assets per share¥3,847.66at 2026-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥3,623.58at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥3,563.63at 2024-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥3,424.59at 2023-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥3,364.03at 2022-03-31vStandaloneNet assets per share (5-year summary)
Equity ratio79.2%at 2026-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.9%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.0%at 2024-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.1%at 2023-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio80.6%at 2022-03-31vStandaloneEquity to asset ratio (5-year summary)
ROE5.0%2025-04-01 → 2026-03-31StandaloneRate of return on equity (5-year summary)
ROE4.2%2024-04-01 → 2025-03-31StandaloneRate of return on equity (5-year summary)
ROE3.7%2023-04-01 → 2024-03-31vStandaloneRate of return on equity (5-year summary)
ROE5.8%2022-04-01 → 2023-03-31vStandaloneRate of return on equity (5-year summary)
ROE8.3%2021-04-01 → 2022-03-31vStandaloneRate of return on equity (5-year summary)
Shares issued36,390,000at 2026-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued36,390,000at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued37,470,000at 2024-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued38,500,000at 2023-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued40,160,000at 2022-03-31vStandaloneTotal number of issued shares (5-year summary)
Employees1,195at 2026-03-31StandaloneNumber of employees
Employees1,237at 2025-03-31StandaloneNumber of employees
Employees1,247at 2024-03-31vStandaloneNumber of employees
Employees1,252at 2023-03-31vStandaloneNumber of employees
Employees1,280at 2022-03-31vStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 1,585
ItemContextValueUnit
Bonuses sgaCurrentYearDuration_NonConsolidatedMember2566000000JPY
Retirement benefit expenses sgaPrior1YearDuration_NonConsolidatedMember495000000JPY
Retirement benefit expenses sgaCurrentYearDuration_NonConsolidatedMember442000000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember11487000000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember12019000000JPY
Commission expensesPrior1YearDuration_NonConsolidatedMember6273000000JPY
Commission expensesCurrentYearDuration_NonConsolidatedMember6461000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2026-06-24
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第88期(自　2025年4月1日　至　2026年3月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)持田製薬株式会社
Company name in english cover pageFilingDateInstantMochida Pharmaceutical Co.,Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　持田　直幸
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都新宿区四谷一丁目7番地
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(3358)7211(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)経理部長　　　　宮本　憲一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都新宿区四谷一丁目7番地
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(3358)7211(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)経理部長　　　　宮本　憲一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00947
Fund codeFilingDateInstant－
Security codeFilingDateInstant45340
Filer name in japaneseFilingDateInstant
Original text (Japanese)持田製薬株式会社
Filer name in englishFilingDateInstantMochida Pharmaceutical Co.,Ltd.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2025-04-01
Current period end dateFilingDateInstant2026-03-31
Type of current periodFilingDateInstantFY
Current fiscal year end dateFilingDateInstant2026-03-31
Previous fiscal year start dateFilingDateInstant2024-04-01
Comparative period end dateFilingDateInstant2025-03-31
Previous fiscal year end dateFilingDateInstant2025-03-31
Next fiscal year start dateFilingDateInstant－
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant－
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant－
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of group (text)FilingDateInstantText · Plus
Business results of reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2026-03-31pass
balance sheet identitynon_consolidated 2025-03-31pass rounding
balance sheet identitynon_consolidated 2026-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2026-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · net assetsnon_consolidated 2026-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2026-03-31pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenueconsolidated 2024-04-01/2025-03-31pass
statement vs summary · revenueconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2025-04-01/2026-03-31pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2026-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass
statement vs summary · total assetsnon_consolidated 2026-03-31pass